These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 31739258)
1. Tumor-specific design of PEGylated gadolinium-based nanoscale particles: Facile synthesis, characterization, and improved magnetic resonance imaging of metastasis lung cancer. Sui Y; Li Y; Li Y; Jin H; Zheng Y; Huang W; Chen S J Photochem Photobiol B; 2020 Jan; 202():111669. PubMed ID: 31739258 [TBL] [Abstract][Full Text] [Related]
2. Zwitterionic Gadolinium(III)-Complexed Dendrimer-Entrapped Gold Nanoparticles for Enhanced Computed Tomography/Magnetic Resonance Imaging of Lung Cancer Metastasis. Liu J; Xiong Z; Zhang J; Peng C; Klajnert-Maculewicz B; Shen M; Shi X ACS Appl Mater Interfaces; 2019 May; 11(17):15212-15221. PubMed ID: 30964632 [TBL] [Abstract][Full Text] [Related]
3. Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies. Mortezazadeh T; Gholibegloo E; Alam NR; Dehghani S; Haghgoo S; Ghanaati H; Khoobi M MAGMA; 2019 Aug; 32(4):487-500. PubMed ID: 30730021 [TBL] [Abstract][Full Text] [Related]
4. Gadolinium oxide nanoparticles and aptamer-functionalized silver nanoclusters-based multimodal molecular imaging nanoprobe for optical/magnetic resonance cancer cell imaging. Li J; You J; Dai Y; Shi M; Han C; Xu K Anal Chem; 2014 Nov; 86(22):11306-11. PubMed ID: 25338209 [TBL] [Abstract][Full Text] [Related]
5. Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer. Cui D; Lu X; Yan C; Liu X; Hou M; Xia Q; Xu Y; Liu R Int J Nanomedicine; 2017; 12():6787-6797. PubMed ID: 28979118 [TBL] [Abstract][Full Text] [Related]
6. PEG coated and doxorubicin loaded multimodal Gadolinium oxide nanoparticles for simultaneous drug delivery and imaging applications. Kumar S; Meena VK; Hazari PP; Sharma RK Int J Pharm; 2017 Jul; 527(1-2):142-150. PubMed ID: 28506803 [TBL] [Abstract][Full Text] [Related]
7. Encapsulation of Gadolinium Oxide Nanoparticle (Gd Mekuria SL; Debele TA; Tsai HC ACS Appl Mater Interfaces; 2017 Mar; 9(8):6782-6795. PubMed ID: 28164704 [TBL] [Abstract][Full Text] [Related]
8. Comparative study on in vivo behavior of PEGylated gadolinium oxide nanoparticles and Magnevist as MRI contrast agent. Dai Y; Wu C; Wang S; Li Q; Zhang M; Li J; Xu K Nanomedicine; 2018 Feb; 14(2):547-555. PubMed ID: 29253637 [TBL] [Abstract][Full Text] [Related]
9. Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616 [No Abstract] [Full Text] [Related]
10. Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene glycol)/Arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres as an Enhanced T Kuang Y; Cao Y; Liu M; Zu G; Zhang Y; Zhang Y; Pei R ACS Appl Mater Interfaces; 2018 Aug; 10(31):26099-26107. PubMed ID: 30016059 [TBL] [Abstract][Full Text] [Related]
11. Toxicity evaluation of Gd2O3@SiO2 nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo. Tian X; Yang F; Yang C; Peng Y; Chen D; Zhu J; He F; Li L; Chen X Int J Nanomedicine; 2014; 9():4043-53. PubMed ID: 25187708 [TBL] [Abstract][Full Text] [Related]
12. RGD-functionalized ultrasmall iron oxide nanoparticles for targeted T₁-weighted MR imaging of gliomas. Luo Y; Yang J; Yan Y; Li J; Shen M; Zhang G; Mignani S; Shi X Nanoscale; 2015 Sep; 7(34):14538-46. PubMed ID: 26260703 [TBL] [Abstract][Full Text] [Related]
13. T Li J; You J; Wu C; Dai Y; Shi M; Dong L; Xu K Int J Nanomedicine; 2018; 13():4607-4625. PubMed ID: 30127609 [TBL] [Abstract][Full Text] [Related]
14. Biocompatibility and potential anticancer activity of gadolinium oxide (Gd Sun X; Kou B BMC Biotechnol; 2024 Aug; 24(1):53. PubMed ID: 39107760 [TBL] [Abstract][Full Text] [Related]
15. Activatable molecular MRI nanoprobe for tumor cell imaging based on gadolinium oxide and iron oxide nanoparticle. Li J; Wang S; Wu C; Dai Y; Hou P; Han C; Xu K Biosens Bioelectron; 2016 Dec; 86():1047-1053. PubMed ID: 27501342 [TBL] [Abstract][Full Text] [Related]
16. Targeted MR Imaging Adopting T1-Weighted Ultra-Small Iron Oxide Nanoparticles for Early Hepatocellular Carcinoma: An Xu YH; Yang J; Meng J; Wang H Chin Med Sci J; 2020 Jun; 35(2):142-150. PubMed ID: 32684234 [TBL] [Abstract][Full Text] [Related]
17. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063 [TBL] [Abstract][Full Text] [Related]
18. Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer. Li X; Xia S; Zhou W; Ji R; Zhan W Int J Nanomedicine; 2019; 14():2397-2413. PubMed ID: 31040664 [TBL] [Abstract][Full Text] [Related]
19. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging. Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208 [TBL] [Abstract][Full Text] [Related]
20. Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging. Li J; Zheng L; Cai H; Sun W; Shen M; Zhang G; Shi X Biomaterials; 2013 Nov; 34(33):8382-92. PubMed ID: 23932250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]